Bromide

Bromide

SCHEMBL9757330

N#Cc1nc2ccc(C[P+](c3ccccc3)(c3ccccc3)c3ccccc3)cc2o1.[Br-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PSMB8 P28062 4/20 0.50
PSMB5 P28074 2/20 0.49
SNCA P37840 2/20 0.38
NOTUM Q6P988 1/20 0.31
APP P05067 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
XDH P47989 2/20 0.30
NLRP3 Q96P20 2/20 0.30
TLR4 O00206 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9757041 0.75 PSMB8 (0.59) PSMB8PSMB5LMNATP53SMN1; SMN2
Bromide SCHEMBL9376893 0.74 SNCA (0.34) SNCACYP3A4LMNATP53
Bromide SCHEMBL9636844 0.70 SNCA (0.37) SNCAXDH
Bromide SCHEMBL7386874 0.70 SNCA (0.44) SNCA
Bromide SCHEMBL7388733 0.69 SNCA (0.43) SNCA
SCHEMBL548913 0.69 PSMB8 (1.00) PSMB8PSMB5ALDH1A1LMNATP53
Bromide SCHEMBL7341008 0.68 SNCA (0.56) SNCASMN1; SMN2
Bromide SCHEMBL1532727 0.67 FOLH1 (0.48) SNCAALDH1A1LMNA
Bromide SCHEMBL6260188 0.67 ALDH1A1 (0.49) SNCAALDH1A1CYP3A4LMNASMN1; SMN2
Bromide SCHEMBL31753766 0.67 TRPV4 (0.45) SNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991019475-A2 QUINOLINYL-BENZOHETEROBICYCLIC DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1991-12-26 WO disclosed
US-5041453-A Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-08-20 US disclosed